Scout Investments, Inc. Neogenomics Inc Transaction History

Scout Investments, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$6.45 - $12.07 $28,696 - $53,699	-4,449 Reduced 1.64%	267,572 $0
Q3 2022 Oct 18, 2022	SELL	$7.86 - $12.91 $60,207 - $98,890	-7,660 Reduced 2.74%	272,021 $2.34 Million
Q2 2022 Jul 15, 2022	BUY	$7.06 - $13.97 $56,183 - $111,173	7,958 Added 2.93%	279,681 $2.28 Million
Q1 2022 Apr 14, 2022	SELL	$12.15 - $35.28 $4,191 - $12,171	-345 Reduced 0.13%	271,723 $3.3 Million
Q4 2021 Jan 14, 2022	SELL	$30.49 - $48.49 $186,781 - $297,049	-6,126 Reduced 2.2%	272,068 $9.28 Million
Q3 2021 Oct 13, 2021	SELL	$41.66 - $52.52 $192,135 - $242,222	-4,612 Reduced 1.63%	278,194 $13.4 Million
Q2 2021 Jul 23, 2021	BUY	$36.62 - $51.69 $1.54 Million - $2.17 Million	41,995 Added 17.44%	282,806 $12.8 Million
Q1 2021 Apr 09, 2021	BUY	$41.56 - $59.88 $988,629 - $1.42 Million	23,788 Added 10.96%	240,811 $11.6 Million
Q4 2020 Jan 12, 2021	BUY	$36.08 - $56.47 $216,480 - $338,820	6,000 Added 2.84%	217,023 $11.7 Million
Q3 2020 Oct 13, 2020	BUY	$33.26 - $40.48 $1.2 Million - $1.46 Million	36,070 Added 20.62%	211,023 $7.79 Million
Q2 2020 Jul 14, 2020	BUY	$24.21 - $31.02 $4.24 Million - $5.43 Million	174,953 New	174,953 $5.42 Million

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.83B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Scout Investments, Inc. with notifications on news.